Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manhattan Scientifics's operating cash flow per share for the
three
months ended in Jun. 2024 was $0.00.
Manhattan Scientifics's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Manhattan Scientifics's Operating Cash Flow per Share or its related term are showing as below:
MHTX's 3-Year OCF Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 12.8 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Manhattan Scientifics Operating Cash Flow per Share Related Terms
Manhattan Scientifics Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Manhattan Scientifics's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manhattan Scientifics Operating Cash Flow per Share Chart
MHTX vs TBIO, CUTRQ, EMED: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Manhattan Scientifics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manhattan Scientifics Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Manhattan Scientifics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Manhattan Scientifics's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.00 mean?
Manhattan Scientifics (MHTX) has a Operating Cash Flow per Share of $0.00 as of Jun. 2024. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Manhattan Scientifics and its competitors.
Is Manhattan Scientifics' Operating Cash Flow per Share too high?
Manhattan Scientifics' current Operating Cash Flow per Share is $0.00.
How does Manhattan Scientifics' Operating Cash Flow per Share compare to TBIO and CUTRQ?
Manhattan Scientifics' Operating Cash Flow per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Operating Cash Flow per Share is 12.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.80, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Manhattan Scientifics and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manhattan Scientifics's current Operating Cash Flow per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manhattan Scientifics stock overvalued right now?
Manhattan Scientifics (MHTX) has a current Operating Cash Flow per Share of $0.00. The current Operating Cash Flow per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Manhattan Scientifics (MHTX), the current Operating Cash Flow per Share is $0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. Its current focus is on the development of nanomaterials through the acquisition of Metallicum.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHTX has been successfully added to your 
